Skip to search.
 NZX 50 Up 0.26%

Keryx Biopharmaceuticals Inc. (KERX)

-NasdaqCM
3.55 Down 0.09(2.47%) 6 Feb 10:00
|After Hours : 3.55 0.00 (0.00%) 6 Feb 10:57
Prev Close:3.64
Open:3.65
Bid:2.90 x 1700
Ask:9.94 x 1000
1y Target Est:10.91
Beta:3.17254
Earnings Date:25 Feb - 29 Feb (Est.)
Day's Range:3.48 - 3.72
52wk Range:2.80 - 14.89
Volume:1,467,348
Avg Vol (3m):1,673,660
Market Cap:373.44m
P/E (ttm):N/A
EPS (ttm):-1.25
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
KERXDown 2.47%373.44m
BAXDown 2.09%20.51b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):45.23
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-1.07
Quarterly EPS Est (Dec-15) :-0.25
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):-0.03

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Its lead product Auryxia (ferric citrate), an oral, ferric iron-based compound that has the capacity ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback